Pylopass is a patented strain of Lactobacillus reuteri that offers a new approach to the control of Helicobacter pylori: primary risk factor for ulcers and gastritis.
Pylopass has a unique mode of action; Lactobacillus reuteri coaggregates specifically with Helicobacter pylori and so reduces its bacterial load in the stomach.

Pylopass also contains zinc, which contributes to:
– The normal acid-base metabolism.
– The normal function of the immune system.
– Normal carbohydrate metabolism and metabolism of fatty acids.

Pylopass is clinicaly proven to treat H. Pylori.